The evidence of circulating adiponectin concentration and risks of RCC and endometrial cancer from prospective epidemiological studies is mixed, with inverse associations reported by some41, 42, 43 studies, but not by others.44, 45. Here, ADIPOQ is linked to renal cell carcinoma.